News &amp; Updates

Apixaban a thromboprophylactic alternative after surgery for GYN cancers?

21 Aug 2020 by

Women undergoing surgery for suspected or confirmed gynaecologic malignant neoplasms* favoured oral apixaban over SC enoxaparin as a prophylactic agent for postoperative venous thromboembolism (VTE**), a study has shown.

Apixaban a thromboprophylactic alternative after surgery for GYN cancers?

Novaferon demonstrates efficacy signal in COVID-19

The recombinant antitumour/antiviral protein novaferon is used to treat hepatitis B virus in China, but a group of investigators finds a signal that it can do something else: induce viral clearance in COVID-19 patients.

Novaferon demonstrates efficacy signal in COVID-19

Gliclazide no better than other sulfonylureas as to obesity-related cancer risk

The risk of obesity-related cancer with gliclazide is comparable to that seen with other sulfonylureas, a study has found.

Gliclazide no better than other sulfonylureas as to obesity-related cancer risk

Some antihypertensive meds tied to lower dementia risk

Calcium channel blockers (CCBs) and angiotensin II receptor blockers (ARBs) may be associated with a reduced risk of dementia, according to a systematic review and network meta-analysis conducted by researchers from the Netherlands.

Some antihypertensive meds tied to lower dementia risk

Compression garments prevent cellulitis in chronic leg oedema

Wearing compression garments daily significantly reduces the rates of recurrent cellulitis than conservative treatment in patients with chronic leg oedema and cellulitis, a study has shown.

Compression garments prevent cellulitis in chronic leg oedema

Metformin improves survival in diabetic patients with bladder cancer

Use of metformin leads to improved oncological outcomes in diabetic patients with nonmuscke invasive bladder cancer treated with intravesical Bacille Calmette-Guerin (BCG), according to a Singapore study.

Metformin improves survival in diabetic patients with bladder cancer

Pimavanserin may cut symptoms of dementia-related psychosis

Use of the antipsychotic drug pimavanserin led to a substantial reduction in psychosis symptoms in individuals with dementia regardless of severity or subtype, according to the results of the HARMONY trial presented at AAIC 2020.

Pimavanserin may cut symptoms of dementia-related psychosis

PPI use may negatively influence COVID-19 outcomes

The use of proton pump inhibitors (PPIs) confers no risk increase for contracting SARS-CoV-2 infection, although PPI users with COVID-19 are likely to have severe outcomes, a study has found.

PPI use may negatively influence COVID-19 outcomes